SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Brushwood, D. B.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Liability Implications of Innovative Drug Therapy: The Significance of Clinical Guidelines in Establishing the Legal Standard of Care

David B. Brushwood, JD

College of Pharmacy, The University of Florida, P.O. Box 100496, Gainesville, FL 32610-0496

The use of the clinical practice guideline (CPG) has become widespread in contemporary health care. For some health care providers, there may be a perceived "safe haven" from liability for strict compliance with a relevant CPG. Pointing to an objective standard, such as a CPG, the health care provider may feel secure in defending care that was provided to a patient, when called to account for a bad outcome. The benefit of any CPG is that it standardizes practice at an acceptably high level. The complimentary risk of a CPG is that it may stifle innovation based on newly discovered or newly appreciated data that were not considered when the CPG was developed. The trend in malpractice law is to recognize a CPG as relevant to the applicable standard of care, but not to equate a CPG with the standard of care. In fact, an outdated CPG may fail to reflect the standard of care, if new scientific or medical knowledge has been validated. The health care provider who adheres to an outdated CPG is at greater risk of liability than the health care provider who spurns the outdated CPG in favor of innovative practice based on valid new information. Innovation, as opposed to experimentation, is recognized as a necessary component of competent health care. The health care provider who adheres to outdated traditional medicine, spurning new developments validated by evidence, has clearly expanded exposure to liability.

Key Words: clinical practice guideline • liability • innovation • standard of practice

Journal of Pharmacy Practice, Vol. 15, No. 3, 279-289 (2002)
DOI: 10.1106/VEXN-Y15M-RU3U


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement